Loading…

Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells

Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells. Intramembrane proteolysis mediated by presenilin/γ‐secretase is known to regulate the homeostasis of some R...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2017-04, Vol.31 (4), p.1382-1397
Main Authors: Lu, Yinzhong, Wan, Jun, Yang, Zhifeng, Lei, Xiling, Niu, Qi, Jiang, Lanxin, Passtoors, Willemijn M., Zang, Aiping, Fraering, Patrick C., Wu, Fang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells. Intramembrane proteolysis mediated by presenilin/γ‐secretase is known to regulate the homeostasis of some RTKs. In the present study, we demonstrate that AXL, but not TYRO3 or MERTK, is efficiently and sequentially cleaved by α‐ and γ‐secretases in various types of cancer cell lines. Proteolytic processing of AXL redirected signaling toward a secretase‐mediated pathway, away from the classic, well‐known, ligand‐dependent canonical RTK signaling pathway. The AXL intracellular domain cleavage product, but not full‐length AXL, was further shown to translocate into the nucleus via a nuclear localization sequence that harbored a basic HRRKK motif. Of interest, we found that the γ‐secretase–uncleavable AXL mutant caused an elevated chemoresistance in non–small‐cell lung cancer cells. Altogether, our findings suggest that AXL can undergo sequential processing mediated by various proteases kept in a homeostatic balance. This newly discovered post‐translational processing of AXL may provide an explanation for the diverse functions of AXL, especially in the context of drug resistance in cancer cells. —Lu, Y., Wan, J., Yang, Z., Lei, X., Niu, Q., Jiang, L., Passtoors, W. M., Zang, A., Fraering, P. C., Wu, F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells. FASEB J. 31, 1382–1397 (2017) www.fasebj.org
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.201600702R